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CopolymerizationPhospholipases A2 have been shown to be activated in a concentration dependent manner by a number of
antimicrobial peptides, including melittin, magainin 2, indolicidin, and temporins B and L. Here we used
ﬂuorescently labelled bee venom PLA2 (PLA2D) and the saturated phospholipid substrate 1,2-dipalmitoyl-
glycero-sn-3-phosphocholine (L-DPPC), exhibiting a lag-burst behaviour upon the initiation of the hydrolytic
reaction by PLA2. Increasing concentrations of Cys-temporin B and its ﬂuorescent Texas red derivative (TRC-
temB) caused progressive shortening of the lag period. TRC-temB/PLA2D interaction was observed by Förster
resonance energy transfer (FRET), with maximum efﬁciency coinciding with the burst in hydrolysis.
Subsequently, supramolecular structures became visible by microscopy, revealing amyloid-like ﬁbrils
composed of both the activating peptide and PLA2. Reaction products, palmitic acid and 1-palmitoyl-2-lyso-
glycero-sn-3-phosphocholine (lysoPC, both at N8 mol%) were required for FRET when using the non-
hydrolysable substrate enantiomer 2,3-dipalmitoyl-glycero-sn-1-phosphocholine (D-DPPC). A novel me-
chanism of PLA2 activation by co-ﬁbril formation and associated conformational changes is suggested.
© 2009 Elsevier B.V. All rights reserved.1. IntroductionPhospholipases A2 (PLA2) constitute a group of ubiquitous
enzymes serving a plethora of functions, from toxicity of insect and
snake venoms to phospholipid metabolism, digestion, cellular signal-
ing, and antimicrobial activity [1]. These enzymes hydrolyze the sn-2
acyl chain from glycerophospholipids to yield free fatty acids (FFA)
and lysophospholipids, and both their catalytic mechanism as well as
structures are conserved, with a high degree of sequence homology
between different species, in particular for secretory PLA2s [1,2].circular dichroism; C-temB,
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ll rights reserved.Similarly to the other lipolytic enzymes, PLA2 exhibits the so-
called interfacial activation: compared to the hydrolysis of monomeric
lipids their activity is dramatically enhanced when reacting with
substrate interfaces [3], such as present in micelles, monolayers, and
bilayers. The enzyme model assumes a change in the PLA2 conforma-
tion to be caused by the interface [4], while the substrate model assigns
the activation to the altered physicochemical properties of the
substrate when present in the interface [5]. Accordingly, the activity
of PLA2 is inﬂuenced by the lipid composition and the phase state of
the substrate phospholipids [6], negatively charged phospholipids [7],
lipid lateral packing density [8], lipid protrusions [9], and membrane
curvature [10,11]. Additionally, the inﬂuence of an electric ﬁeld [12]
and effects by membrane associating small molecules have been
reported (for a brief recent account see Code et al. [13]). Changes in
PLA2 conformation upon interfacial activation have been demon-
strated and it was suggested that enzyme conformational alterations,
in unison with the physical state of the substrate, would cause the
augmented catalytic activity [14,15]. Notably, Hille et al. as well as
Dennis and co-workers concluded the activation of PLA2 to be
accompanied by its aggregation at interfaces [16,17], as visualized in
1,2-dipalmitoyl-sn-glycero-3-phosphocholine (L-DPPC) monolayers
[18-20]. More detailed characteristics of the aggregated PLA2 were
recently described by us [13], providing evidence for the activation of
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oligomers. Formation of ﬁbrillar structures upon the action of PLA2 on
supported phosphatidylcholine bilayers was recently observed by
AFM [21].
Several amyloidogenic peptides, e.g. amyloid Aβ-peptides [8], and
several antimicrobial peptides (AMPs), e.g. temporin B (temB) and
temporin L, indolicidin, magainin 2 [22], LL-37 [23], bombolitin III
[24], and melittin [25,26], enhance the activity of PLA2. Character-
istically these peptides are cationic and amphiphilic, promote the
segregation of negatively charged phospholipids, and partition into
membranes [27,28]. In order to pursue the mechanism of the
activation of PLA2 by AMPs in more detail we used C-temB
(CLLPIVGNLLKSLL-CONH2), i.e. temB with an additional N-terminal
cysteine. The latter allows an easy covalent labelling with ﬂuorophore
maleimide and we have shown a Texas Red derivative of this peptide
(TRC-temB) to have essentially similar antimicrobial and lipid binding
properties as the natural temB [29]. TemB belongs to temporins, a
family of AMPs now comprising of 76 different peptides, isolated from
the skin of the European red frog, Rana temporaria [30]. The
amphipathicity and net positive charge of temB allows it to penetrate
into membranes and concentrate on negatively charged membranes,
segregating with anionic lipids [28]. TemB thus efﬁciently perturbs
lipid bilayers and causes membrane permeabilization [28,31,32].
Analogously to most AMPs characterized so far, the membrane
intercalation of temB is prevented by cholesterol [28,29]. Similarly
to LL-37, plantaricin A, and another member of the temporin family,
temporin L, temB as well as TRC-temB have been shown in model
membranes to aggregate and form amyloid-like Congo-red staining
ﬁbers, driven by both electrostatics and hydrophobicity [29,33,34].
Here we report the activation of bee venom PLA2D by TRC-temB to
be accompanied by a shortening of the lag time and an augmented
burst in the hydrolysis of a saturated phospholipid substrate, DPPC.
We demonstrate close interactions between the peptide and the
enzyme, as observed by Förster resonance energy transfer (FRET). At
the end of the reaction, sub-millimetre amyloid-like ﬁbrils composed
of both PLA2D and TRC-temB were present. TemB is suggested to
promote the nucleation of the growth of amyloid-like ﬁbrils by PLA2,
resulting in the formation of peptide-enzyme coﬁbrils, which causes a
conformational change in the enzyme, yielding an augmented
expression of its catalytic activity.
2. Materials and methods
2.1. Materials
L-DPPC was from Avanti Polar Lipids (Alabaster, AL), and D-DPPC
and 1,2-dihexadecyl-sn-glycero-3-phosphocholine (DHPC) from
Sigma-Aldrich. Thin layer chromatography of these lipids was
performed on silicic acid coated plates (Merck, Darmstadt, Germany)
developed with a chloroform/methanol/water mixture (65:25:4, v/
v/v). Examination of the plates after iodine staining revealed no
impurities. Bee venom PLA2 was from Sigma and its purity was
veriﬁed by polyacrylamide gel electrophoresis in the presence of
sodium dodecyl sulphate (PAGE). Fluorescent labels Alexa Fluor 488
carboxylic acid, succinimidyl ester, and Texas Red C2 maleimide were
from Invitrogen/Molecular Probes (Eugene, OR). All other chemicals
were of analytical grade and from standard sources. Concentrations of
the lipid stock solutions in chloroform were determined gravime-
trically with a high-precision electrobalance (Cahn, Cerritos, CA), as
described in detail by [35,36]. Freshly deionized ﬁltered water (Milli
RO/Milli Q, Millipore Inc., Jeffrey, NH) was used in all experiments.
Protein, lipid, and CaCl2 solutions were prepared and passed through a
0.2 μm ﬁlter (Schleicher and Shuell Microscience, Dassel, Germany)
prior to use. C-temB (CLLPIVGNLLKSLL-CONH2) was from Synpep
(Dublin, CA) and its purity was checked by HPLC (purityN95%) and
sequence conﬁrmed by mass spectrometry [29].2.2. Preparation of labelled phospholipase A2 and temporin B
Covalent coupling of the Alexa 488 ﬂuorophore to PLA2 was
conducted following the instructions of the manufacturer of the dye.
The concentration of PLA2 was calculated from UV spectra using
E1%280=13.0 and MW=15,249 [37]. The concentration of the
carboxylic acid succinimidyl ester of the Alexa 488 dye
(MW=643.4) was determined using a molar extinction coefﬁcient
of 71,000 M−1cm−1 at 495 nm. Absorption spectra were measured
with a spectrophotometer (Perkin Elmer Lambda Bio40 UV/Vis,
Boston, MA) using 10 mm path length quartz cuvettes (Hellma,
Essex, UK) and 2 nm bandpass. For labelling 0.2 mM PLA2 and
0.3 mM dye were reacted for 1 h at 25 °C with magnetic stirring and
protected from light in a total volume of 100 μl of 100 mM Na2HCO3,
pH 8.3. At this pH the dye couples primarily to aliphatic amines.
Chromatography on prepacked columns (Biospin 6, Hercules, CA)
with an exclusion limit of 6000 Da was used to change the buffer to
5 mM HEPES, 0.1 mM EDTA, pH 7.5, and to remove any unreacted
dye. The extent of labelling (dye to protein molar ratio) was
determined by UV spectroscopy. Correction factor for the extinction
coefﬁcient in the determination of the dye content of the labelled
enzyme at 280 nm was 0.11. The ﬁnal dye/protein molar ratio varied
from 0.6:1 to 1:1, as indicated. The labelled enzyme was stored in
20 μl aliquots at −20 °C prior to use. The bee venom PLA2 was
chosen for the current study as it has been shown to bind to lipid
membranes by non-electrostatic interactions with no preference for
negatively charged phospholipids over zwitterionic ones [37].
Therefore, even though the ﬂuorescent label used by us is expected
to react with Lys residues this should have an insigniﬁcant effect on
the primary enzyme-substrate interaction between the labelled PLA2
and DPPC.
Labelling of Cys-temporin B (C-temB) was performed as
described by Sood et al.[29]. In brief, a 1:1 molar ratio mixture of
C-temB and Texas Red maleimide at ﬁnal concentrations of 50 μM in
20% acetonitrile, 20 mM Hepes, 0.1 mM EDTA, pH 7.0 was incubated
for 3 h at room temperature in the dark with magnetic stirring.
Labelled peptide was puriﬁed by reversed phase HPLC (μRPC C2/
C18/ ST 4.6/100 column, ÄKTA Puriﬁer, Amersham) eluting with a
gradient of 10 to 80% acetonitrile with 0.05% triﬂuoroacetic acid. No
unreacted Texas Red maleimide was detected indicating that the
peptide was completely labelled. This was further conﬁrmed by
mass spectrometry using Flex Control MALDI-TOF spectrometer
(Bruker Daltonics, Bremen, Germany) and a saturated solution of α-
cyano-4-hydroxycinnamic acid as a matrix. The concentration of the
Texas Red labelled peptide was determined using molar extinction
coefﬁcient of 112,000 M−1cm−1 at 589 nm. No major inﬂuence by
the ﬂuorophore on the lipid binding properties of temB was
observed [29]. Apparently, the hydrophobicity of the latter exceeds
as such, without the contribution of the hydrophobicity of the
ﬂuorophore, what is needed for the proper lipid binding of this
peptide.
2.3. Assessment of the lag-burst behaviour in the PLA2 reaction
Similarly to other PLA2s the bee venom enzyme shows a distinct
lag time γ in its hydrolytic action on DPPC liposomes [13], deﬁned as
the latency period between the addition of the enzyme and the burst
in the catalytic rate. The lag was determined by measuring the
decrease in pH with a miniature electrode (Microelectrodes, Bedford,
New Hampshire, USA) inserted into the ﬂuorescence cuvette (see
below). Importantly, as we only wanted to observe the lag period and
deﬁne the time point of the subsequent burst we did not correct for
the decrement in pH by titration with a base. Accordingly, only
semiquantitative data on the PLA2 activity are obtained. The burst was
determined as the intersection point of the linear ﬁts to the pH curve
during the lag and the initial phase of rapid hydrolysis. For saturated
Fig. 2. Lag time γ (in min) in the action of PLA2 on DPPC, shown as a function of peptide
concentration. The enzyme-peptide combinations were C-temB and PLA2 (○), TRC-
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considerably with temperature, having minimum at the main phase
transition Tm [6,38]. In order to have a clearly discernible lag the
experiments described herein were performed at 37 °C. Under the
conditions employed (viz. 200 μM DPPC, 75 nM PLA2D, T=37 °C) a
latency period of about 30 min preceded the burst in activity evident
as a decrease in pH (Fig. 1A; Fig. 2). In our previous study [13] we
observed no major difference in the lag for the labelled and native
PLA2. This may reﬂect the less extensive labelling (approximately
64%) and the higher temperature (40 vs 37 °C) used in our earlier
experiments. With PLA2D at a 1:1 dye:protein ratio used here, the lag
was somewhat prolonged compared to the native enzyme (30 vs.
15 min, respectively, Fig. 2). The observed differences in γ are likely to
further result from minor variations in the actual amount of enzyme
added. The degree of labelling is difﬁcult to control. In addition, the
carboxylic acid succinimidyl esters of Alexa-488 can react with one (or
more) of the twelve lysines of the bee venom phospholipase A2. The
labelling ratio is determined from spectra, but we have not
determined the location of the label. Yet, although the covalent
labelling introduces an extra moiety to the protein, the characteristic
lag-burst behaviour is retained, thus validating the use of PLA2D for
the purposes of this study.Fig. 1. Time course for FRET between PLA2D and TRC-temB during the hydrolysis of
DPPC liposomes monitored as a function of time, with simultaneous measurement of
pH to observe the burst. (A) Hydrolysis of the DPPC substrate monitored as a function of
time by a decrease in pH. (B) Emission of PLA2D at λ=520 nm upon excitation at
λex=460 nm (donor channel), emission of TRC-temB at λem=613 nm upon excitation
at λex=460 nm for PLA2D (FRET channel). Medium was water with 1 mM CaCl2 at
37 °C. TRC-temB (0.1–0.5 μM) was ﬁrst added to the DPPC as indicated, followed after
3 min by the addition of PLA2D (75 nM ﬁnal concentration). Initial DPPC concentration
was 200 μM. The data for 0 μM peptide for panel B and Fig. 5B are from different
experiments. The same conditions were used but the experiments were performed on
different days. Microheterogeneities of the DPPC liposomes from the different
experiment days may change the curves slightly.
temB and PLA2D (▴, data from Fig. 1), C-temB and PLA2D (●, data from Fig. 5), TRC-
temB and PLA2 (△, data from Fig. 4), peptide and enzyme added sequentially, and
PLA2D and TRC-temB added simultaneously (pre-mixed) (■, data from Fig. 6).2.4. FRET
Fluorescence spectra were measured with a spectroﬂuorometer
(Cary) in magnetically stirred 10mm path length, four window quartz
cuvettes thermostated at 37 °C. Unless otherwise indicated all
measurements were carried out in a ﬁnal volume of 1 ml containing
200 μM DPPC or DHPC LUV in 1 mM CaCl2 (unbuffered), with the
reactions started by the addition of the indicated amount of temB
followed after three min by the addition of PLA2 (ﬁnal enzyme
concentration of 75 nM). Fluorescence of PLA2D (donor) was
measured with excitation at 460 nm and emission at 520 nm and
that for TRC-temB (acceptor) with excitation at 460 and emission at
613 nm. Bandpasses of 5 nm were used for the excitation and 10 nm
for emission. Fluorescence and pH were recorded simultaneously as a
function of time using an in-house written script.
2.5. Circular dichroism
CD spectra were measured in a 0.1 mm pathlength quartz cuvette
thermostated at 35 °C with a Jasco J-500A spectropolarimeter (Jasco,
Tokyo, Japan). Themeasurements were carried out in a ﬁnal volume of
200 μl in 1 mM CaCl2 (unbuffered water). Individual spectra were
recorded for temB (40 μM), PLA2 (15 μM) and temB with PLA2 added
together (40 and 15 μM, respectively). Three averaged scans were
recorded from 290 nm to 190 nm, using 1 nm bandwidth, 0.2 nm
resolution, 1 s response time, and a scan speed of 20 nm/min.
2.6. Microscopy
Aliquots (200 μl) were taken from the one ml samples of the above
indicated experiments into clear glass bottom 96 well plates (Greiner
Bio-One, Germany). All experiments were carried out at room
temperature (approximately 24 °C). Images were acquired from the
microscope ﬁttedwith a colour digital camera (DS6031, Canon Europe,
Amsterdam, The Netherlands). Confocal ﬂuorescence microscopy was
performed using an inverted microscope (IX 70, Olympus, Tokyo,
Japan) equipped with a spinning disk confocal scanner (CSU10,
Yokogawa, Tokyo, Japan) and a krypton argon ion laser (Melles Griot,
Carlsbad, CA). The argon line at 488 nm and a band-pass ﬁlter (512–
539 nm, green channel) was used for PLA2D visualization, and the
Fig. 4. Time course for FRET between unlabelled PLA2 and increasing concentrations of
TRC-temB during hydrolysis of DPPC liposomes, monitored as a function of time. (A)
Simultaneous measurement of pH to observe the burst. (B) Emission of TRC-temB at
λem=613 nm upon excitation at λex=460 nm (FRET channel). TRC-temB (0.1–0.5 μM)
was ﬁrst added to the DPPC substrate, followed after 3 min by the addition of PLA2
(75 nM ﬁnal concentration). Conditions were as described in the legend for Fig. 1.
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channel) for TRC-temB. Fluorescence images were collected using a
Peltier-cooled 12-bit B/W CCD camera (C4742-95, Hamamatsu,
Hamamatsu City, Japan) interfaced to a computer and operated by
the software (AquaCosmos 1.2) provided by the cameramanufacturer.
Additional image processing was done using ImageJ software
developed at NIH/RSB [39]. Formation of ﬁbres was conﬁrmed by
examining eight wells with identical samples containing both
liposomes and the enzyme with/without peptide against eight
samples containing buffer or buffer and liposomes as controls. These
experiments were repeated three times with a consistent number of
ﬁbres appearing in the samples. No ﬁbres were observed in the
negative controls.
3. Results
TemB as well as several other AMPs have been shown to increase
the activity of PLA2 [22]. In order to pursue the mechanisms of this
activation in more detail we used TRC-temB, a ﬂuorescent derivative
of this peptide, obtained by reacting C-temB, i.e. temB with an
additional N-terminal cysteine, with Texas red maleimide. This
ﬂuorescent peptide has similar lipid-binding and antimicrobial
properties as the native temB [29]. To investigate how the peptide
affects the early stages of the interfacial activationwe used a saturated
phospholipid matrix, L-DPPC, close to its main phase transition
temperature, i.e. a system where the lag-burst behaviour is observed
[40]. When 0.1 μM TRC-temB was added to the DPPC substrate 3 min
before the enzyme addition (Fig. 1A), the lag time decreased from 30
to 9 min (Fig. 2). A further progressive decrease was observed with
increasing concentrations from 0.2 to 0.5 μM TRC-temB. Similar
decrements in the lag were observed for the native enzyme with TRC-
temB (Fig. 4A), PLA2D with C-temB (Fig. 5A) and both enzyme and C-
temB lacking the ﬂuorophore (data not shown). Further decrement in
the lag timewas seenwhen PLA2D and TRC-temB weremixed prior to
their addition to the DPPC liposomes (Fig. 2 and 6). Thus, the presence
of temB shortens the latency phase of the phospholipid hydrolysis in a
concentration dependent manner.
Possible interactions of PLA2 and temB were studied using FRET
between ﬂuorescently labelled enzyme (PLA2D, donor) and peptide
(TRC-temB, acceptor). Kinetic measurements were conducted over
time with increasing amounts (0.1–0.5 μM) of TRC-temB added 3 min
prior to the addition of PLA2D (Fig. 1B). A minor increase inFig. 3. FRET between PLA2D and TRC-temB interacting with DPPC liposomes. Spectra
were recorded for PLA2D alone (solid line), PLA2D with TRC-tempB (dashed line), and
TRC-temB alone (dotted line). The excitation wavelength was 460 nm for all spectra.
Spectra were recorded 5 min after the addition of PLA2D to DPPC with 0.1 μM of TRC-
temB. Other conditions were as described in the legend for Fig. 1.ﬂuorescence was observed in the FRET channel (donor excitation at
460 nm, acceptor emission at 613 nm) when the TRC-temB (acceptor)
was added to the liposomes. This increase in ﬂuorescence is due to
(residual) direct excitation of the acceptor at the donor excitation
wavelength. Following the addition of the donor-labelled enzyme
(PLA2D), the ﬂuorescence in the donor channel (donor excitation at
460 nm, and donor emission at 520 nm) decreased gradually during
the lag phase reaching a minimum at the burst of enzymatic activity
and then returning back to the initial level during the ﬁrst 5–10 min of
hydrolysis. At the same time, reciprocal changes were observed in the
FRET channel with the energy transfer between the labelled enzyme
and peptide reaching a maximum at the burst point (Fig. 1).
Furthermore, in the presence of increasing concentrations of TRC-
temB the FRET maximum progressively shifted to earlier times
(Fig. 1B), exactly paralleling the shortening of the lag period (Fig. 2)
measured from the decrement in pH (Fig. 1A).
FRET was evident in the ﬂuorescence emission measured in the
presence of the DPPC substrate liposomes for co-added PLA2D and
TRC-temB and comparing these spectra with those for TRC-temB and
PLA2D alone (Fig. 3). The spectra were obtained in the latency phase,
2 min after the addition of PLA2D to the liposomes. The excitation
wavelength used was 460 nm, which matches the donor (Alexa 488)
absorption peak, and also causes a weak direct excitation of Texas Red
acceptor. The sample where the donor and acceptor were combined
exhibited reduced intensity of PLA2D (donor; emission band around
520 nm) and enhanced intensity of TRC-temB well above the direct
excitation level (acceptor; emission band around 610 nm) when
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phase of DPPC hydrolysis, energy transfer occurred between the
ﬂuorophores attached to PLA2 and temB, thus revealing their close
association at this stage. Taken together, the FRET changes suggest
progressive association between PLA2 and temB during the latency
phase peaking simultaneously with the burst of activity.
In control experiments we used non-labelled PLA2 and TRC-temB
(Fig. 4), as well as PLA2D and the non-labelled C-temB (Fig. 5). For
PLA2 and TRC-temB a slight increase in the FRET channel is observed
(Fig. 4B). This increase in ﬂuorescence may be due to a change in the
peptide emission in the DPPC or a direct interaction of TRC-temB with
PLA2. However, Texas Red is rather insensitive to microenvironment
factors so a change in the peptide conformation may not be observed
in this system. In the second set of experiments, using PLA2D and the
non-labelled C-temB, the ﬂuorescence of PLA2D decreased slightly at
the burst. However, the decrease in donor ﬂuorescence (Fig. 5B all
curves) and increase in acceptor ﬂuorescence (Fig. 4B) was less than
observed for the enzyme-peptide FRET pair (Fig. 1B). This conﬁrms
that the ﬂuorescence changes shown in Fig. 1 arise from FRET, and are
not due to the ﬂuorescence changes of the individual ﬂuorophores of
the FRET pair. Similar decrements in the lag were observed for the
native enzyme with TRC-temB (Fig. 4A), PLA2D with C-temB (Fig. 5A)
and both enzyme and C-temB lacking the ﬂuorophores (data not
shown). Additionally, TRC-temB and PLA2 were coadded in the
presence of liposomes to observe whether the peptide and protein can
interact before they associate on the liposome interface (Fig. 6). A
decrease in donor ﬂuorescence and an increase in acceptor ﬂuores-Fig. 5. Lag-burst behavior for FRET by PLA2D in the presence of unlabelled C-temB
during hydrolysis of DPPC liposomes. (A) The hydrolysis of the DPPC substrate was
monitored as a function of time by decrease in pH. (B) Emission of PLA2D at
λem=520 nm upon excitation at λex=460 nm (donor channel). C-temB (0.1–0.5 μM, as
indicated) was ﬁrst added to the DPPC, followed after 3 min by the addition of PLA2D
(75 nM ﬁnal concentration). Conditions were as described in the legend for Fig. 1.
Fig. 6. Time course of FRET between PLA2D and TRC-temB (pre-mixed before addition
to DPPC) during hydrolysis of DPPC liposomes, with simultaneous measurement of pH
to observe the burst. (A) The hydrolysis of the DPPC substratemonitored as a function of
time by decrease in pH. (B) Emission of PLA2D at λ=520 nm upon excitation at
λex=460 nm (donor channel) and emission of TRC-temB at λem=613 nm upon
excitation at λex=460 nm of PLA2D (FRET channel). TRC-temB (0.1–0.5 μM, as
indicated) and 75 nM PLA2D were mixed and added to DPPC liposomes (indicated by
the arrow). Conditions were as described in the legend for Fig. 1.cence was observed (Fig. 6, panel B) with a less pronounced effect
than in Fig. 1. The lag time also decreased for the simultaneous
addition (Fig. 6A).
As a further control and in order to gain further molecular insight
we observed the effect of hydrolysis products on the change in FRET,
using the non-hydrolysable enantiomer D-DPPC (Fig. 7A). Differential
scanning calorimetry showed identical thermal phase behavior for D-
DPPC (data not shown) in our systemwhen compared to L-DPPC [41].
No evidence for aggregation of the liposomes containing products was
observed by dynamic light scattering (data not shown). At 0% and
with 5 mol% products only a slight increase in FRET and a slight
decrease in donor ﬂuorescence were observed. However, with 8, 10
and 15 mol% of both palmitic acid and lysoPC a progressively
enhanced FRET was seen with a concomitant decrease in the donor
ﬂuorescence (Fig. 7A and B). With an increase in products the FRET
enhancement increased with a parallel and opposite change in donor
quenching (Fig. 7C). Thus, the reaction products from the PLA2
reaction are needed to induce peptide-PLA2 interaction seen by FRET.
Interactions between PLA2 and temB were investigated also using
CD. These spectra (Fig. 8A and B) show that PLA2 and temB interact
on the surface of L-DPPC liposomes. PLA2 in the presence of temB
increases the absorbance at 208 nm with a signiﬁcant spectral shift
but no change is detected at 190 nm. Subtracting the spectra for
temB as such from the spectra measured for the coadded peptide
and enzyme does not abolish this change (Fig. 8A). Furthermore, the
temB spectrum changes in the presence of PLA2 showing a larger
Fig. 7. (A) FRET between PLA2D and TRC-temB interacting with D-DPPC liposomes and increasing amount of hydrolysis products lysoPC:Palmitic Acid (1:1 molar ratio) as indicated.
Full spectra were recorded for PLA2D with TRC-temB. (B) Corrected spectra for TRC-temB acceptor enhancement. (C) Donor quenching and acceptor enhancement as a function of
increasing amount the products. The excitationwavelengthwas 460 nm. Spectrawere recorded 3min after the addition of PLA2D to D-DPPCwith (products at 0, 5, 8,10,15mol%) and
0.1 μM of TRC-temB. Other conditions were as described in the legend for Fig. 1.
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A change in temB from a random coil to a more α-helical
conformation occurs at different peptide lipid ratios (see Appendix,
S3).
Both temB and PLA2 form, in the presence of negatively charged
lipids, amyloid-type ﬁbres [13,29] and for PLA2 we have suggested
that this process causes a conformational change into a transient high
activity state [13]. Along these lines, we hypothesized that the
formation of heterooligomers by PLA2 and temBwould be responsible
for the activation by temB of PLA2, promoting enzyme aggregation
into an active conformation. Subsequently, this would be followed byFig. 8. Circular Dichroism PLA2 and temB with DPPC liposomes. Measurements were
carried out in a ﬁnal volume of 200 μl in 1mMCaCl2 (unbuffered water) with DPPC LUV.
Individual spectra were recorded for DPPC LUV (200 μM, ○), PLA2 with temB (15 μM
and 40 μM, ■). (A) PLA2 alone (15 μM, △), PLA2 spectral subtraction (□). (B) temB
alone (40 μM, ▽), temB spectral subtraction (◊). Three averaged scans of CD were
measured. Spectra were recorded 35 °C from 290 nm to 190 nm, using 1 nm bandwidth,
0.2 nm resolution, 1 s response time, and a scan speed of 20 nm/min.the formation of ‘mature’ amyloid ﬁbers, with the enzyme switching
into an inactive state. Supporting this mechanism, examination of the
reaction mixture (approxim. 1 h after the enzyme addition) under a
bright ﬁeld microscope revealed macroscopic ﬁbres (N100 μm in
length, Fig. 9A). Interestingly, these ﬁbrils were ﬂuorescent in both the
green (PLA2D) and red (TRC-temB) channels (Fig. 9B and C,
respectively). The intensity observed in the red channel (Fig. 9C) is
higher than in the green channel (Fig. 9C). These data can be
rationalized by i) the higher TRC-temB concentration compared to
PLA2D, and ii) FRET from the PLA2D to the TRC-temB. In addition,
there is a poorly understood loss of ﬂuorescence due to the formation
of amyloid-like ﬁbres [42].
4. Discussion
To summarize, C-temB, and TRC-temB decrease the latency phase
of PLA2when added to DPPC liposomes (Figs.1, 3–6). The activation of
PLA2 through reduction of the lag phase in phospholipid hydrolysis
could be explained by at least two distinct mechanisms. First, the
activation could be mediated by a perturbation of the lipid bilayer
structure caused by peptide binding. Indeed, temB binding and
insertion cause extensive short-range (i.e. enhanced lipid acyl chain
order and segregation of negatively charged lipids, [28,31] as well as
long-range perturbation of the bilayer structure [43]. Second, temB
can directly bind PLA2 and form supramolecular structures, thus
activating the enzyme directly by altering its conformation.
Subsequent to the burst, following the onset of maximal hydrolysis
the vesicles disrupt and the lipid organization changes dramatically
with complex and poorly understood polymorphism [44-46]. Opti-
cally, this is evident as a pronounced increase in light scattering after
the burst, as demonstrated in several studies (e.g. [10], Fig. 1 in
reference [13]). While detailed understanding of the molecular
arrangements during the reaction would obviously be interesting,
taking into account the massive transformation in the 3-D organiza-
tion, we are not aware of a technique, which would make it possible to
keep track of intervesicular contacts and the origin of the different
components in the aggregate. Importantly, in the current study we
were interested in the process resulting in the activation of PLA2,
Fig. 9. Fibrils formed after reacting DPPC with PLA2D and TRC-temB as described for Fig. 1. Aliquots (200 μl) of the reaction mixture taken 1 h after starting the reaction were
transferred from cuvettes into a 96 well plate for ﬂuorescence microscopy. (A) shows a bright ﬁeld DIC image of a ﬁbril. Fluorescence image of 0.4 μM TRC-temB with 75 nM PLA2D
coﬁbrils using λex=488 nm and λem=512–539 nm ﬁlters (green ﬂuorescence, (B), and λex=568 nm and λem=585–625 nm ﬁlters (red ﬂuorescence, (C) of the same ﬁbril. The
scale bar corresponds to 20 μm.
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literature data and our observations show that the light scattering
during the lag is very close to the scattering level of individual
liposomes, revealing that there is no signiﬁcant liposome aggregation
or morphological transformations preceding the burst.
Increasing the concentration of TRC-temB from 0.1 μM to 0.5 μM
progressively decreased the lag. The shortest lag was observed when
PLA2 and the peptide were mixed before their addition to the
phospholipid substrate. However, using anisotropy and FRET we did
not ﬁnd any evidence for an interaction in solution with just the
protein and peptide present (in the absence of liposomes, data not
shown). It is possible that in solution at low ionic strength
electrostatic repulsion repel the peptide and protein from each
other, as they both have a net positive charge at neutral pH. It is
possible, that the complex formation resulting in PLA2 activation
would be most efﬁcient, when PLA2 and temB are in the conforma-
tions prevailing immediately following their surface association. To
this end, both PLA2 and temB are known to undergo conformational
changes upon transfer from solution to the lipid interface, further
connected to aggregation and formation of amyloid-type ﬁbers
[13,29,47]. Association with the negatively charged reaction product
(FFA) overcomes the electrostatic repulsion between the peptide and
enzyme on the surface of substrate bilayer, allowing interaction to
occur, as demonstrated by our FRET experiments with bee venom
PLA2 and temB. Our CD data demonstrate interaction of PLA2 and
temB on the surface of DPPC (Fig. 8A and B) and a change in temB from
a random coil to a more α-helical conformation at different peptide
lipid ratios (see Appendix, S3).
Changes in enzyme conformation at the burst have been demon-
strated, as observed by us using Alexa-488 and Alexa-568 labelled
PLA2 [13], while Bell et al. [10] reported an increase in the intrinsic Trp
ﬂuorescence of PLA2. Here we show an increase in acceptor
ﬂuorescence (FRET) when the donor is added (Fig. 3). The FRET
data was corrected to take into account this increase in donor
ﬂuorescence in the spectra. We observed the full spectra containing
both donor and acceptor over a number of time points and found that
the increase in donor ﬂuorescence was independent of a FRET
increase. Homotransfer or homoFRET may take place for identical
ﬂuorophores such as BODIPY that display a small Stokes shift [48]. For
the probe used with bvPLA2D, Alexa-488, the Stokes shift is larger and
homoFRET is small. In addition homoFRET will not lead to a change in
ﬂuorescence emission or a change in the lifetime because excitation
energy is transferred to the same probe. HomoFRET does increase the
depolarization when there is an increase in the concentration of
probes in a viscous solution. As homoFRET should not affect the
emission intensity, it is unlikely that this process would be involved in
the system studied here.
FRET was observed between the TRC-temB and the PLA2D (Fig. 1)
when reacting with the DPPC substrate, indicating a direct TRC-tempB and PLA2D interaction on the surface. With increasing
concentrations of TRC-temB there was a progressive increase in
FRET, with a maximum at the burst in the enzyme activity for PLA2D.
PLA2 produces lysoPC and negatively charged FFA prior to the burst
point and a critical content of these products is required to initiate
the burst [20]. TemB has been shown to segregate anionic lipids in a
binary membrane [28]. The lag-burst behavior and the changes in
chemical composition (accumulation of the reaction products) have
been very thoroughly characterized in previous studies [10,49,50]. In
brief, these results show very slow, time dependent accumulation of
the products until at the burst approx. 8 mol% of both fatty acid and
lysoPC (1:1 stoichiometry) have been formed. At this point, the
enzyme activity increases very rapidly, resulting in a signiﬁcant large
scale reorganization of the remaining substrate and the reaction
products, readily visible as pronounced aggregation and turbidity.
Accordingly, we only needed to observe the burst point, which is
most easily detected by the rate of decrease in pH, as described in
several earlier studies [10,38]. For an efﬁcient FRET a hydrolysable
interface is needed viz. L-DPPC and Ca2+ need to be present. Further,
the catalytic activity is needed for peptide-protein association and in
the presence of EDTA FRET is not observed. This is evident with both
DPPC and POPC as a substrate (data not shown). After the enzyme
addition several minutes are needed before FRET increases, with a
parallel decrease in donor ﬂuorescence. It is apparent that this local
accumulation of hydrolytic products is needed for oligomerization of
the PLA2 at the interface. Furthermore, this local accumulation of the
hydrolytic products FFA and lysoPC during the lag appears to be
needed also for TRC-temB-PLA2D association, as a substantial and an
increasing intensity of FRET is seen with increasing amounts of
products present in D-DPPC liposomes. The reaction products viz.
lysoPC and FFA added into a non-hydrolysable substrate enantiomer
D-DPPC increase FRET between the PLA2D and TRC-temB (Fig. 7).
Vesicle size measurements of D-DPPC liposomes with different
concentrations of products by dynamic light scattering measure-
ments revealed no evidence for vesicle aggregation. Therefore, FRET
is a consequence of the temB-PLA2 association on the surface of
individual liposomes (Fig. 7).
Cholesterol attenuates the association of temB with phospholipid
bilayers [29] and Bell et al. showed [51] that a high content of
cholesterol protects cells from hydrolytic enzymes such as PLA2. They
also showed that the behavior of PLA2 in this respect is comparable in
biological membranes and in model membranes. Similar biophysical
studies by Simonsen show that cholesterol is a key lipid in regulating
PLA2 activation and suggests that cholesterol is able to partially or
completely block the activation of PLA2 on ternary model membranes
[52]. While the effects of cholesterol are of interest, experiments
described here aimed to the clariﬁcation of the mechanism of
activation of PLA2 by temB. The effects of cholesterol are likely to be
complex and warrant an extensive study of its own.
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venom, has been shown to both activate and inhibit PLA2
depending on its concentration [25,26,53] and this activation
correlates with the formation of a complex that involves PLA2,
melittin, phospholipid substrate, and Ca+2 [25]. Similarly to temB
melittin is capable of penetrating and solubilizing membranes [54],
and possesses antimicrobial activity. We have recently suggested
the interfacial activation of PLA2 to be caused by the emergence of
highly active enzyme oligomers, existing as intermediates in the
aggregation-refolding path yielding at the end inactive amyloid-
type ﬁbres [13]. In line with the above, we hypothesized that the
formation of heterooligomers by PLA2 and temB would underlie the
activation of this enzyme by the latter AMP, which also forms itself,
in the presence of negatively charged lipids, amyloid-type ﬁbres
[29]. In the light of the present results this would be feasible. First,
our data show speciﬁc lipid structures (FFA and lysoPC) to be
required for close association of temB and PLA2, seen by FRET
(present study and Code et al., to be published). Second, under
conditions where activation is seen, also amyloid-type ﬁbrils are
seen, whereas in the absence of the reaction products these ﬁbres
do not form. In the zwitterionic DPPC liposomes temB as such does
not form ﬁbrils. Third, the ﬁbres incorporate both TRC-temB and
PLA2D, as seen by their ﬂuorescence. The amount of lipids and
placement of lipids in the amyloid-like structure is not clearly
understood however. The other membrane partitioning and amyloid
formation prone, PLA2 activating AMPs mentioned above may form
similar supramolecular complexes.
Amyloid formation seems to be required also for the activation of
PLA2 by the Alzheimer Aβ fragments. Accordingly, peptide fragments
Aβ1−42 and Aβ25−35 activate PLA2 whereas Aβ1−25 has no effect [8].
Our data show that temB promotes amyloid coﬁbril formation
with PLA2 in the lipid membrane. TemB may serve as “molecular
glue” ﬁtting in between the PLA2 monomers and oligomers and
thus promoting PLA2 oligomerization, via the formation of
catalytically active heterooligomers. Heterooligomers have been
observed between α-synuclein upon seeding with bovine insulin,
lysozyme, and insulin ﬁbrils [55]. Glyceraldehyde-3-phosphate
dehydrogenase has been found to coaggregate with α-synuclein
[56]. It has been speculated that IAPP may induce nucleation of
oligomer formation, thus promoting neuronal disorders [57,58]. In
this context it is of interest that also apolipoprotein C-II (apoC-II), a
peptide activator of another lipolytic enzyme, lipoprotein lipase
(LPL), forms amyloid, and this amyloid formation is enhanced by
lipids [59]. Furthermore, the lipoprotein lipase activating domain of
apoC-II coincides with the amyloid forming residues of this
apolipoprotein [60]. In this regard, while several possibilities have
been proposed [61,62], the mechanism of activation of lipoprotein
lipase by apoC-II has remained elusive. Our current results tempt
speculation along analogous lines to the activation of PLA2 by temB
described here, viz. the formation apoC-II/LPL amyloid-type
heterooligomers.
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